ECMO support in SARS-CoV2 multisystem inflammatory syndrome in children in a child

Shubhi Kaushik1, Neha Ahluwalia2, Sandeep Gangadharan1

  • 1Department of Pediatrics, Division of Critical Care Medicine, Kravis Children's Hospital at Mount Sinai, New York, USA.

Perfusion
|September 9, 2020
PubMed

Insights

This report details a rare case of a 5-year-old boy with severe COVID-19-related MIS-C, requiring ECMO. The case highlights the first pediatric stroke associated with SARS-CoV-2 infection.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Neurology

Background:

  • Multi-system inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection can lead to severe illness.
  • Early diagnosis of MIS-C can be challenging, especially with negative initial viral tests.
  • Neurological complications, including stroke, are increasingly recognized in pediatric COVID-19 cases.

Observation:

  • A 5-year-old previously healthy male presented with respiratory failure and vasoplegic shock due to MIS-C.
  • Initial SARS-CoV-2 reverse transcription-polymerase chain reaction (RT-PCR) testing was negative, but antibody testing was positive.
  • The patient required mechanical ventilation, vasopressors, and extracorporeal membrane oxygenation (ECMO) for refractory shock and respiratory failure.

Findings:

  • Echocardiogram showed mildly depressed left ventricular function without coronary anomalies.
  • The patient developed a middle cerebral artery infarct and left frontal subarachnoid hemorrhage.
  • This represents the youngest reported case of MIS-C requiring ECMO and the first pediatric stroke linked to SARS-CoV-2.

Implications:

  • This case underscores the potential for severe, multi-systemic complications of SARS-CoV-2 in children, including neurological events.
  • It emphasizes the importance of considering MIS-C in children with severe illness, even with negative initial viral tests.
  • The findings highlight the need for further research into the pathophysiology and management of SARS-CoV-2-related neurological complications in pediatric populations.